Novo Holdings Buyout Sends Catalent Stock Surging

The shares of pharmaceutical concern Catalent Inc (NYSE:CTLT) are surging today, after news that Novo Holdings, the controlling shareholder of Novo Nordisk (NVO), is purchasing the company for $11.5 billion. The merger will help Novo meet strong demand for weight-loss drug Wegovy, increasing its filling capacity starting in 2026. On the charts, CTLT has been chopping higher since mid-November. Today's jump still isn't enough to close its April bear gap, though, which occurred after a Danaher (DHR) takeover ...